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OrganogenesisNotch signaling has been shown to mediate a wide array of cell fate decisions during development. While
previous work has demonstrated that Notch signaling plays an important role in regulating cardiac
differentiation and morphogenesis, an earlier role during cardiac ﬁeld formation has not yet been fully
characterized. Previously, our lab demonstrated that perturbations in Notch signaling beginning at the onset
of gastrulation affect the subdivision of germ layers. However due to the potential additive effects of
misregulating Notch signaling over multiple stages of development, it was not possible to distinguish a
speciﬁc role for this pathway during heart ﬁeld speciﬁcation. Here, we developed an innovative approach
that takes advantage of temporally inducible constructs to isolate our manipulations to speciﬁc windows of
development. In particular, we focused our studies on some of the earliest stages of cardiogenesis when heart
ﬁeld speciﬁcation occurs. Our ﬁndings demonstrate a novel role for Notch signaling during the prepatterning
of the cardiac mesoderm. Speciﬁcally, once relieved of aberrantly activated Notch signaling following
gastrulation, cardiac precursors retain the ability to express markers of the cardiac ﬁeld. Conversely,
downregulating Notch signaling in cells fated to become heart tissue results in the induction of cardiac ﬁeld
genes in gastrula embryos. Finally, we provide evidence suggesting that this new role for Notch signaling is
mediated at least in part via the Notch effector protein, Esr9 and the transcription factor GATA4. Taken
together, these ﬁndings provide strong evidence for a novel role for Notch signaling in regulating the timing
of heart ﬁeld speciﬁcation during early cardiogenesis.© 2009 Elsevier Inc. All rights reserved.IntroductionIt has long been recognized that Notch signaling mediates a wide
variety of cell fate decisions during vertebrate development (Artava-
nis-Tsakonas et al., 1999; Brennan and Gardner, 2002; Harper et al.,
2003; Lai, 2004; Schweisguth, 2004; Weinmaster, 1997; Weinmaster,
1998). Identiﬁed genetically in Drosophila nearly 100 years ago, the
Notch gene encodes a 300-kDa transmembrane protein receptor
which functions at the cell surface to bind transmembrane ligands
(Delta or Jagged/Serrate) on adjacent cells. Upon ligand binding, a
series of proteolytic cleavages releases the intracellular domain (ICD)
of Notch allowing for translocation of the ICD into the nucleus. This
cleavage product mediates the function of Notch in the nucleus by
interacting with the Suppressor of Hairless [Su(H)] transcription
factor to activate downstream target genes. The primary downstream
effectors of Notch signaling have been identiﬁed as members of the
Hairy/Enhancer of split (HES) and Hey families of repressive basic
helix–loop–helix (bHLH) transcription factors (Davis and Turner,
2001; Iso et al., 2003).Laughlin).
l rights reserved.The ability of Notch signaling to regulate such a wide array of cell
fate decisions suggests that the activity of this pathway is mediated by
different target genes within the various cell types. This is supported
by studies that have shown that HES and Hey family members are
dynamically expressed within a developing embryo, and regulate
different developmental events (Jen et al., 1999; Lamar and Kintner,
2005; Pasini et al., 2004; Pichon et al., 2002; Rones et al., 2002; Takke
et al., 1999; Tsuji et al., 2003). Recently, researchers have begun to
focus on identifying and characterizing the HES and/or Hey down-
stream mediators of Notch signaling responsible for regulating the
function of this pathway in speciﬁc cell types (Lopez et al., 2005; Tsuji
et al., 2003).
Over the years, the role of Notch signaling has beenwidely studied
during various stages of heart development. The expression of Notch
signaling components during the differentiation and morphogenesis
of the vertebrate heart has previously been characterized in numerous
vertebrate species (Del Amo et al., 1992; Loomes et al., 1999, 2002;
Myat et al., 1996; Reaume et al., 1992; Rones et al., 2000; Westin and
Lardelli, 1997; Williams et al., 1995). Indeed, several groups have
characterized a role for Notch in suppressing cardiomyogenesis
following cardiac speciﬁcation, and have demonstrated that muta-
tions in Notch pathway members cause a number of morphological
cardiac defects, such as atrial and ventricular septal defects consistent
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cardiovascular disease (Beis et al., 2005; Garg et al., 2005; Han and
Bodmer, 2003; Li et al., 1997; Lorent et al., 2004; McCright et al., 2002;
Oda et al., 1997; Rones et al., 2000; Schroeder et al., 2003). Although
these and similar studies describe a critical role for Notch signaling
during the later stages of cardiac development, an earlier role for this
pathway during cardiac speciﬁcation and ﬁeld formation has not yet
been examined.
Many of the initial steps involved in forming the cardiac ﬁeld have
been described in Xenopus laevis. Mostly comprised of mesodermally
derived cell types, the amphibian heart ﬁeld is speciﬁed during
gastrulation (Nascone and Mercola, 1995; Sater and Jacobson, 1989).
At the onset of gastrulation, presumptive precardiac cells lie as paired
primordia 30–45° on either side of the dorsal midline (Sater and
Jacobson, 1990). As gastrulation proceeds, these cardiac progenitor
cells migrate laterally, eventually fusing at the ventral midline. It is
here at this ventral location that the differentiation and morphogen-
esis of cardiac tissue takes place (Mohun et al., 2003). Importantly,
inductive interactions of the precardiac mesodermwith the dorsal lip
and organizer regions, as well as the underlying deep dorsoanterior
endoderm, are critical for proper acquisition of heart-forming potency
(Lough and Sugi, 2000; Nascone and Mercola, 1995; Sater and
Jacobson, 1989, 1990; Schneider et al., 1999; Schultheiss et al., 1995).
More recently, the transcriptional networks responsible for proper
heart development have been investigated. For example, GATA4 and
nkx2.5 encode transcription factors necessary for the subsequent
activation of genes leading to the formation of cardiac muscle, such as
MHCα and cardiac actin (Chen et al., 1996; Molkentin et al., 1994;
Sepulveda et al., 1998). While Nkx2.5 is considered the ﬁrst molecular
marker identifying precardiac cells, the characterization of its
promoter has revealed multiple binding sites for GATA factors and
for Nkx2.5 itself (Brewer et al., 2005; Brown et al., 2004; Klinedinst
and Bodmer, 2003; Lien et al., 1999; Reecy et al., 1999; Searcy et al.,
1998). Such evidence suggests that GATA factor expression may
precede Nkx2.5 in the cardiac transcriptional network. Indeed,
numerous studies have demonstrated that the upregulation of
GATA4 precedes Nkx2.5 expression in stem cells induced to
differentiate along a cardiac lineage in culture, and also regulates
Nkx2.5 expression in vitro and in vivo (Brewer et al., 2005; Brown et
al., 2004; Grepin et al., 1997; Klinedinst and Bodmer, 2003; Reecy et
al., 1999). Interestingly, although GATA-family members are dynami-
cally expressed during gastrulation (Fletcher et al., 2006), the heart
mesoderm does not typically express cardiac ﬁeld genes until well
after gastrulation is completed and the prospective heart cells are
properly located at the ventral midline.
Numerous studies have demonstrated that Notch pathway players
are expressed during gastrulation at a time when the heart ﬁeld is
speciﬁed (Abe et al., 2004; Appel et al., 1999; Coffman et al., 1990;
Contakos et al., 2005; Kikuchi et al., 2004; Kiyota et al., 2001; Latimer
et al., 2002; Lopez et al., 2003, 2005; Ma et al., 1996; Wittenberger et
al., 1999). Additionally, our previous work demonstrated that
aberrant activation of Notch signaling in the developing gastrula
results in decreased expression of mesodermally expressed tran-
scripts including the heart (Contakos et al., 2005). Conversely, the
downregulation of Notch signaling resulted in the expansion of
mesodermal genes beyond their normal domains (Contakos et al.,
2005). These ﬁndings not only identiﬁed an earlier role for Notch
signaling during early development, but also suggested that this
pathway may be functioning to regulate or restrict the ability of cells
to contribute to the embryonic heart ﬁeld. Since Notch signaling can
regulate cell fate decisions by inhibiting differentiation and main-
taining precursor cell populations (Austin et al., 1995; Dorsky et al.,
1995; Ishiko et al., 2005; Lawson et al., 2001; le Roux et al., 2003;
Wang et al., 1998; Ye et al., 2004), we examined whether a similar
role for Notch signaling was occurring at gastrula stages to speciﬁcally
prepattern the cardiac ﬁeld.We report here that transcripts of the Notch pathway compo-
nents, Xotch, Delta1, Esr10, and Esr9 are expressed in the precardiac
mesoderm throughout gastrulation but are eventually excluded from
these cells once they have migrated to their ﬁnal destination at the
ventral midline. Importantly, we characterized the signiﬁcance of
maintaining Notch signaling for only a short, discrete developmental
window of early cardiac formation using a dual-hormone approach.
We demonstrate that the transient upregulation of Notch signaling
during speciﬁcation of the heart ﬁeld results in a delay in the
differentiation of cardiac precursors. Interestingly, unlike the
observed reduced heart ﬁeld that results when Notch signaling is
extended through early tailbud stages (Contakos et al., 2005), when
signaling levels are attenuated towards the end of gastrulation,
cardiac ﬁeld marker expression is restored. In contrast, the down-
regulation of this pathway during this developmental window results
in robust expression of cardiac ﬁeld markers (e.g., nkx2.5, tbx5,
GATA4) in the migrating heart mesoderm, prior to reaching their ﬁnal
destination at the ventral midline. Moreover, of the numerous Notch
target genes expressed in the presumptive mesoderm during
gastrulation, we show that only a subset of genes are Notch-
responsive in the developing precardiac mesoderm. Upregulation of
such Notch-responsive genes results in a similar inhibition of cardiac
ﬁeld marker expression as is observed when Notch signaling is
upregulated. Finally, we demonstrate that the upregulation of GATA4
rescues cardiac ﬁeld gene expression resulting from aberrant
activation of Notch signaling mediated via the Notch-responsive
effector protein, Esr9. Such ﬁndings are the ﬁrst to characterize a role
for Notch signaling during a discrete developmental window during
the speciﬁcation and formation of the embryonic heart ﬁeld and
suggest a new role for Notch signaling during the prepatterning of
the cardiac mesoderm.
Materials and methods
Embryo culture
Female adult Xenopus laevis were induced to ovulate by injection
of chorionic gonadotropin into the dorsal lymph sac and eggs were
fertilized in vitro. Embryos were dejellied in 2% cysteine solution and
maintained in 0.1× Marc's Modiﬁed Ringer's solution (MMR; 1 M
NaCl, 20 mM KCl, 10 mM MgCl2, 20 mM CaCl2, 50 mM HEPES, pH 7.5)
(Peng and Kay, 1991). Embryos were reared at 14–22 °C and staged
according to Nieuwkoop and Faber (1994).
Microinjection of mRNA
CappedmRNAwas synthesized in vitrousing themMessageMachine
kit (Ambion). Embryos were injected into one or two dorsovegetal
blastomeres at the 2–8 cell stagewith 100 pg of nuclear β-galactosidase
mRNA as a lineage tracer and 200–800 pg of mRNA(s) encoding
temporally inducible constructs to upregulate Notch signaling [GR-Su
(H)VP16 or GR-NotchICD] and/or downregulate Notch signaling [GR-Su
(H)DBM]. GR-Su(H)VP16, GR-NotchICD, and GR-Su(H)DBM are described
in more detail elsewhere (Contakos et al., 2005; Kiyota et al., 2008;
McLaughlin et al., 2000; Ogino et al., 2008; Pirot et al., 2004; Rones et al.,
2000, 2002; Wettstein et al., 1997). All GR-fusion constructs were
induced via the addition of a synthetic glucocorticoid, dexamethasone,
to the culturemedium(ﬁnal concentration 10 μM). For experiments that
required the induction of injected constructs via a different hormone, an
estrogen-inducible version of the Su(H)DBM construct [ER-Su(H)DBM]
was created. Brieﬂy, Su(H)DBMwas fused in-frame to the ligand-binding
domain of the human estrogen receptor (a gift of Thomas Gilmore)
using the BamHI/ClaI sites of pCS2-Su(H)DBM to create an estrogen-
inducible construct. Site-directedmutagenesis (Stratagene)was used to
create a translation start codon in the ERdomain. Theﬁnal constructwas
conﬁrmed via DNA sequence analysis.
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regulation of cardiac ﬁeld formation, 400 pg of GATA4-ER or GATA4-
GR was injected alone or with mRNAs designed to upregulate Notch
signaling as described above. The estrogen-inducible GATA4 construct
was made by PCR ampliﬁcation of the full-length GATA4 sequence
(GATA4-GR; a gift of R. Patient) fused in-frame to the ligand-binding
domain of the human estrogen receptor (via insertion into the ClaI/
XhoI site of pCS2+). The ﬁnal construct was veriﬁed by DNA sequence
analysis. The role of the Notch target gene, Esr9, was examined via
injecting embryos with 400 pg of Esr9-GR (a gift of E. Bellefroid) alone
or in combination with the GATA4-ER construct described above.
Injected embryos were cultured in 0.1× MMR until they reached
the desired stages. Injected constructs were induced by the addition of
the appropriate hormone (1 μM 17β-estradiol and/or 10 μM dex-
amethasone [Sigma]) to the culture medium and cultured in the
presence of hormone until ﬁxation. At appropriate stages, embryos
were ﬁxed in MEMFA (0.1 M MOPS pH 7.4, 2 mM EGTA, 1 mMMgSO4,
3.7% formaldehyde), rinsed in 1× PBS and incubated at 37 °C in
staining solution (20 mM, K3Fe(CN)6, 20 mM K4Fe(CN)6·3H2O, 2 mM
MgCl2, 0.01% SDS, and 0.02% NP-40) with the substrate magenta-gal
(Sigma) to allow for the detection of β-galactosidase activity. After
detection of the lineage label, embryos were rinsed in 1× PBS and
post-ﬁxed in MEMFA for 1 h.
In situ hybridization
To detect expressed transcripts, embryos were hybridized with
digoxygenin-labeled antisense RNA probes as previously described
(Harland, 1991). Hybridizations were performed on whole or
manually bisected embryos and chromogenic detection of digoxy-
genin-labeled probes was performed using an anti-digoxygenin
antibody conjugated to alkaline-phosphatase (Roche) to deposit a
dark blue BCIP/NBT precipitate. Embryos were post-ﬁxed for 1 h in
MEMFA and dehydrated in methanol for storage at −20 °C. Probes
used included: nkx2.5 (Tonissen et al., 1994), tbx5 (Horb and Thomsen,
1999) GATA4 (Jiang and Evans, 1996), esr9/10 (Li et al., 2003), xotch
(Coffman et al., 1990), delta1 (Chitnis et al., 1995), delta2 (Jen et al.,
1997), serrate1 (gift from Chris Kintner), cardiac actin (Mohun et al.,
1984), tni (Drysdale et al., 1994), mhcα (Logan and Mohun, 1993),
lim-1 (Taira et al., 1994); pax8 (Carroll et al., 1999), and evi1 (Mead
et al., 2005). Observed phenotypes were documented using a Nikon
SMZ-1500 Stereo Microscope (Spot Insight Color Camera) using
standard microscopy. After in situ hybridization analysis, embryosFig. 1. The expression of the Notch receptor xotch and ligand delta1 in the precardiac mesode
for the expression of xotch and delta1 in gastrula and early neurula embryos. Gastrula-stage w
panels (A–D). The plane of the midsagittal sections of sibling embryos (A’, B’, C’, D’) is denot
pole at the top. Early neurula-stage embryos are dorsal views with anterior toward the top in
reveals expression of the Notch receptor (xotch) and ligand (delta1) at the onset of gastrulat
side of embryos and is retained in cells migrating along the blastocoel roof (A–D’; arrow h
reached early neurula stages, the expression of both xotch and delta1 has becomemore restric
xotch and delta1 are expressed in the neural plate, but expression does not extend to the mwere post-ﬁxed in MEMFA for 1 h, rinsed in 1× PBS, and stored in
methanol.
Results
Expression of xotch and delta1 during gastrulation suggests a role for
Notch signaling in patterning of the precardiac mesoderm
To begin to address the question of whether signaling through
Notch plays a role in the prepatterning of the cardiac mesoderm, the
expression of the Notch receptor xotch, and Notch ligands delta1,
delta2, and serrate1 were examined via in situ hybridization analysis.
Interestingly in gastrula embryos, a time when heart ﬁeld speciﬁca-
tion is initiated (Nascone and Mercola, 1995; Sater and Jacobson,
1989), the expression of both the receptor, xotch, and a Notch ligand,
delta1, is detected in the presumptive mesoderm of the marginal zone
in a characteristic ring pattern that narrows toward the dorsal side of
the embryo (Figs. 1A–B’). At slightly later stages (stg. 11.5), analysis of
whole mount and midsagittal sections reveals that cells migrating
along the blastocoel roof maintain xotch and delta1 expression
(Figs. 1C–D’). At early neurula stages, after gastrulation movements
are completed, the expression of xotch and delta1 is diminished in
the developing precardiac mesoderm and is now restricted to other
cell types including the presomitic mesoderm and cells of the
developing nervous system (Figs. 1E–F’).
While delta2 is expressed in a similar ring pattern at gastrula
stages (Abe et al., 2004), the expression of the other Notch ligand,
serrate1, was not detected via in situ hybridization in the marginal
zone during the stages examined (Kiyota et al., 2001). The expression
patterns described above serve to further reﬁne and verify those
reported by others demonstrating the dynamic expression of Notch
pathway players during gastrulation (Abe et al., 2004; Coffman et al.,
1990; Kiyota et al., 2001; Lopez et al., 2003, 2005; Ma et al., 1996;
Wittenberger et al., 1999).
The Notch effector genes, esr9 and esr10, are expressed in the marginal
zone and are responsive to Notch signaling during gastrulation
Additional evidence that Notch signaling plays a role in pre-
patterning the developing mesoderm stems from studies that reveal
downstream effectors of Notch belonging to the HES family of
transcription factors are expressed in the marginal zone of gastrula
embryos (Cui, 2005; Li et al., 2003; Taelman et al., 2004; Tsuji et al.,rm during early cardiogenesis. Embryos were examined by in situ hybridization analysis
hole embryos are viewed from the vegetal pole with the dorsal side located at the top of
ed by a dashed line in adjacent panels. Midsagittal sections are viewed with the animal
(E, F), and anterior views with dorsal to the top in (E’, F’). In situ hybridization analysis
ion in the presumptive mesoderm of the marginal zone that narrows toward the dorsal
eads denote location of migrating xotch and delta1 positive cells). Once embryos have
ted and is now expressed primarily in neural cell types (E–F’). Anterior views show that
ore ventrally located cardiac ﬁeld at these stages (E’, F’; full arrows).
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downstream target genes might be responsive to changes in Notch
signaling during cardiac speciﬁcation, we used hormonally inducible
forms of the transcription factor Su(H) to misregulate Notch signaling
at a desired time without affecting earlier developmental events
(Contakos et al., 2005; Kiyota et al., 2008; McLaughlin et al., 2000;
Ogino et al., 2008; Pirot et al., 2004; Rones et al., 2000, 2002;
Wettstein et al., 1997). Cleavage-stage embryos were injected with
mRNAs encoding either GR-Su(H)VP16 to upregulate Notch signaling
or GR-Su(H)DBM to downregulate Notch signaling. At the onset of
gastrulation, the hormone dexamethasone was added to the culture
medium to induce injected GR-fused constructs. One hour after
hormone addition, embryos were ﬁxed and processed for in situ
hybridization analysis. Only a subset of the HES genes that are
normally expressed in the marginal zone, esr9 and esr10, was found to
be responsive to changes in Notch signaling levels at these stages
(Fig. 2). For example, the aberrant activation of Notch signaling
during gastrulation resulted in an expansion of esr9 expression in
77% of embryos (n= 120) and esr10 expression in 82% of embryos
(n= 82) examined. Analogous molecular phenotypes were observed
when GR-NotchICD was used to upregulate Notch signaling, provid-
ing additional evidence that esr9/10 are Notch-responsive genes at
these stages (esr9 75% of embryos examined, n= 36; esr10 73% of
embryos examined, n= 41). Similar experiments upregulating Notch
signaling via injected GR-Su(H)VP16 or GR-NotchICD constructs
conﬁrmed these molecular phenotypes using PCR analysis (data not
shown). In contrast, suppression of Notch signaling had the opposite
effect, where a decrease or ablation of esr9 and esr10 expression was
observed (esr9 68% of embryos, n=96; esr10 75% of embryos,
n= 52). Altogether these results further support a role for Notch
signaling during the establishment of the cardiac mesoderm, and
suggest that this role might be mediated at least in part by the
downstream target genes, esr9 and esr10.Fig. 2. The HES genes esr9 and esr10 are Notch-responsive in marginal zone mesoderm
during gastrulation. All images are gastrula stage whole embryos viewed from the
vegetal pole. (A, D) In situ hybridization analysis of uninjected embryos shows that the
expression of the putative downstream Notch effector genes, esr9 and esr10, are
expressed in the marginal zone in a ring pattern coinciding with delta, and xotch
expression (Fig. 1). Embryos were co-injected with a lineage label and either GR-Su(H)
VP16 to upregulate Notch signaling (B, E) or GR-Su(H)DBM to downregulate the Notch
pathway (C, F). Constructs were induced at the onset of gastrulation by the addition of
dexamethasone to the culture medium and collected 1 h later. Arrowheads indicate the
location of the progeny of the injected cells as detected by the presence of magenta-gal-
positive nuclei. (B, E) An expansion of esr9 and esr10 expression resulted when Notch
signaling was upregulated (esr9 78% of embryos, n= 120; esr10 82% of embryos,
n= 82) and decreased expression was observed when Notch signaling was down-
regulated (esr9 68% of embryos, n= 96; esr10 75% of embryos, n= 52). On average, 21%
or less of both uninjected-control embryos and injected embryos not exposed to
hormone were observed to contain alterations in normal esr9 and esr10 expression
(normal esr9 expression was observed in: 91% of embryos injected with GR-Su(H)
VP16/no hormone, n= 104; 85% of embryos injected with GR-Su(H)DBM/no hormone,
n= 128; normal esr10 expressionwas observed in: 91% of embryos injected with GR-Su
(H)VP16/no hormone, n= 57; 79% of embryos injected with GR-Su(H)DBM/no
hormone, n= 91). Percents represent the number of embryos with the phenotype
described resulting from three replicate experiments conducted on different days.Manipulation of Notch signaling during a ﬁnite window of
cardiac development
In our previous work examining the consequences of misregulated
Notch signaling on germ layer formation, we showed that while
activation of Notch signaling at the onset of gastrulation caused a
reduction in cardiac ﬁeld marker expression, the suppression of this
pathway resulted in the opposite effect (Contakos et al., 2005). While
this work served to provide some important initial insights, a
limitation of the reagents used was that once induced, the injected
constructs used to manipulate Notch signaling remain active for the
duration of the experiment. Thus, although we were able to control
when the injected constructs were ﬁrst induced, the effects of
manipulating Notch signaling would be additive and continue until
embryos were ﬁxed and analyzed at later stages.
Because signaling through Notch mediates multiple developmen-
tal events, the former approach for conditionally modulating Notch
signaling fails to distinguish a discrete role for Notch during a ﬁnite
window of development, from the potential additive effects that could
result from misregulating signaling over a prolonged period of time.
Therefore, to extend and reﬁne previous studies, we took advantage of
constructs that could be induced independently via two different
hormones. This strategy is based, in part, on work performed by
Wettstein et al. (1997) demonstrating that co-injection and co-
induction of the activated and dominant negative forms of Su(H)
rescues the altered phenotypes observed when either form of Su(H) is
injected individually. Accordingly, if the induction of the Notch
suppressing Su(H)DBM construct can be regulated independently of
the wild-type version of Su(H), perturbations in endogenous Notch
signaling levels can be isolated to a speciﬁc window of time.
To begin to understand the role of Notch signaling speciﬁcally
during the establishment of the cardiac mesoderm, two constructs,
GR-Su(H)VP16 (induced by the addition of dexamethasone) and ER-
Su(H)DBM (induced via the addition of 17β-estradiol) were used. Since
the heart arises from two separate ﬁelds of cells during development,
embryos were injected unilaterally with mRNAs encoding the
appropriate Su(H)-fusion construct(s), allowing the opposite, unin-
jected side of the embryo to serve as an internal control. After
injection, the individual hormones were added to the culture media at
the desired stages of development to induce the corresponding
construct. The effects of perturbing Notch signaling during a speciﬁc
window of development were then evaluated by examining the
expression of a panel of genes on the injected and uninjected sides of
embryos. Several controls, including uninjected sibling embryos with
and without hormone and injected embryos not exposed to hormone,
were also examined.
Before co-injecting the two Notch constructs, their individual
efﬁcacy was evaluated (Figs. 3A, B). Similar to results described
previously (Contakos et al., 2005), a reduction of the cardiac ﬁeld
marker nkx2.5 at early tailbud stages was observed in the GR-Su(H)
VP16/Dex10 treatment group (82% of embryos, n= 91) (Fig. 3A). To
assess whether the decreased expression was simply a delay in the
cardiogenic program, embryos were also examined at later stages,
after the heart ﬁelds fuse and cardiac differentiation genes are
normally expressed. To circumvent possible compensation from the
uninjected side of embryos, both blastomeres fated to create the heart
ﬁelds were injected. Notch signaling was induced at the onset of
gastrulation and allowed to persist until later stages of cardiogenesis.
Comparable to what was observed at early tailbud stages, even when
embryos developed until older stages, nkx2.5 expression remained
greatly reduced (data not shown).
As Fig. 3B illustrates, the induction of the newly created ER-version
of Su(H)DBM resulted in phenotypes similar to those observed when
the original GR-fused construct [GR-Su(H)DBM; Contakos et al., 2005]
was used to downregulate Notch signaling (increased nkx2.5 expres-
sion in 75% of embryos, n= 60) (Fig. 3B). Chi-squared analysis
Fig. 3. Co-expression and co-induction of GR-Su(H)VP16 and ER-Su(H)DBM rescues normal gene expression. Embryos were co-injected with GR-Su(H)VP16 and/or ER-Su(H)DBM and
either dexamethasone (Dex), 17β-estradiol (E2), or both hormones were added to the culture medium at stage 10, when heart ﬁeld speciﬁcation begins. Embryos were examined for
nkx2.5 expression via in situ hybridization at tailbud stages. The percents on the graph summarizing these data represent the number of embryos from three experiments observed to
contain an aberrant molecular phenotype (increase or decrease) on the injected side of the heart ﬁeld as compared to normal nkx2.5 expression on the uninjected side of the same
embryo (n= 50–100 animals for each treatment group). (A)When GR-Su(H)VP16 is injected alone and its expression is induced with dexamethasone to upregulate Notch signaling,
nkx2.5 expression is dramatically decreased (treatments: Dex10 82% of embryos, n= 91; no hormone control 5% of embryos, n= 97). (B) Conversely, when ER-Su(H)DBM is injected
alone and its expression is induced by 17β-estradiol to suppress Notch signaling, an increase in nkx2.5 gene expression is observed (treatments: E210 75% of embryos, n= 60; no
hormone control 17% of embryos, n= 76). (C) Co-injection of GR-Su(H)VP16 and ER-Su(H)DBM plus the addition of only one of the two hormones, resulted in similar molecular
phenotypes to those observed in embryos injectedwith one of the two Notch constructs (compare to A, B). As before, upregulated Notch signaling decreased nkx2.5 expression in the
heart ﬁeld (63% of embryos, n= 54) and downregulation of Notch expanded nkx2.5 expression (68% of embryos, n= 63). However, when the two co-injected Notch constructs were
simultaneously induced via addition of both hormones (Dex10 and E210) to the culture medium, a rescue of the individual mutant phenotypes was observed (nkx2.5 normally
expressed in 66% of embryos, n= 80). (D) Representative images of embryos co-injected with GR-Su(H)VP16 and ER-Su(H)DBM and either dexamethasone (Dex),17β-estradiol (E2),
or both hormones were added to the culture medium at stage 10. Ablated nkx2.5 expression in the Dex(10) treatment is restored in the dual-hormone treatment. Arrows indicate
injected side of embryos. White line marks midline of ventral views of tailbud stage embryos.
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fused constructs whereas GR-fused constructs could only be induced
via the addition of dexamethasone (Figs. 3A, B; χ2=135, df=5,
p b0.001). Uninjected embryos reared in one or a combination of
hormones did not exhibit any abnormal morphology or gene
expression through stage 46 (data not shown).
Next, the feasibility of using a dual-hormone approach to
manipulate Notch signaling during a speciﬁc period of development
was evaluated. mRNAs encoding GR-Su(H)VP16 and ER-Su(H)DBM
were co-injected into one blastomere along with the lineage label β-
galactosidase (Figs. 3C, D). At the onset of gastrulation, individual
hormones (dexamethasone or 17β-estradiol/E2) or a combination of
both hormones (Dex and E2) were added to the culture medium. Prior
to the fusion of the two heart ﬁelds at the ventral midline, the
expression of cardiac genes on the injected side and uninjected side of
embryos was examined by in situ hybridization. Importantly, as
reported by Wettstein et al. (1997), when both constructs were co-
injected and co-induced the expression of nkx2.5 remained compar-
able on the injected and uninjected side of embryos (expression
remained unaltered in 66% of embryos, n=80) (Figs. 3C, D). This
rescue is in sharp contrast to the extreme alteration in nkx2.5
expression observed when only one of the two hormones was added
to embryos previously co-injected with both constructs (increased
expression in 68% of embryos co-injected and exposed to only 17β-
estradiol, n=63; decreased expression in 63% of embryos co-injected
and exposed to only dexamethasone, n=54; χ2 =75.61, df=3,p b0.001) (Figs. 3C, D). Similar patterns of gene expression were
observed when additional cardiac genes (e.g., tbx5, cardiac actin), and
Notch-responsive genes (e.g., serrate1, esr9) were examined (data not
shown). Taken together, these data demonstrate that the dual-
hormone reagent system facilitates the examination of Notch signaling
during speciﬁc, discrete windows of early heart development.
Notch signaling delays the differentiation of cardiac precursor
populations during speciﬁcation of the embryonic heart ﬁeld
To evaluate the consequences of manipulating Notch signaling
during a ﬁnite window of heart ﬁeld formation, one blastomere of
cleavage-stage embryos was co-injected with GR-Su(H)VP16 and ER-
Su(H)DBM. Notch signaling was upregulated via the addition of
dexamethasone at the onset of gastrulation, just prior to the
speciﬁcation of the cardiac ﬁeld. At the end of gastrulation, after
heart speciﬁcation is completed, 17β-estradiol was added to induce
ER-Su(H)DBM and moderate the effects of activating Notch signaling.
Embryos were raised to tailbud stages and examined for the
expression of cardiac transcripts. Unlike the dramatic reduction of
cardiac markers observed when Notch signaling persisted from the
onset of gastrulation through tailbud stages, when the perturbation of
Notch signaling was restricted to the window of development between
stages 10–14, nkx2.5 expression appeared normal when examined at
tailbud stages (85% of embryos normal nkx2.5 expression, n=101)
(Fig. 4). Similar results were obtained using GR-NotchICD to induce
Fig. 4. The loss of cardiac ﬁeld marker expression resulting from the aberrant activation
of Notch during early cardiogenesis can be rescued. Time course data demonstrates that
if ectopically upregulated Notch signaling is not dampened by early neurula stages
(stage 14), then cardiac gene expression cannot be recovered. Notch constructs, GR-Su
(H)VP16 and ER-Su(H)DBM, were co-injected into one blastomere at early cleavage
stages. The aberrant activation of Notch signaling at stage 10 (Dex10; onset of
gastrulation) was moderated via the addition of 17β-estradiol (E2) at the stages
indicated on the graph. Prior to the fusion of the two heart ﬁelds at the ventral midline
(stgs. 23–25), embryos were examined for the expression of nkx2.5 mRNAs via in situ
hybridization analysis. These data represent the percent of embryos from three separate
experiments with normal nkx2.5 expression on both sides of the embryo (normal
nkx2.5 expression on injected and uninjected sides), n= 45–81 animals for each
treatment group. As the graph illustrates, as long as ectopically upregulated Notch
signaling is abrogated by early neurula stages, the expression of the heart ﬁeld gene
nkx2.5 is normally expressed at tailbud stages. However, if upregulated Notch signaling
is maintained throughout neurulation, the ability to rescue the patterning of the cardiac
ﬁeld is dramatically reduced.
Fig. 5. The reduction of renal gene expression resulting from upregulated Notch signaling d
VP16 and/or ER-Su(H)DBM and inducing hormones were added at the stages indicated. Emb
hybridization at tailbud stages. The percents on the graph summarizing these data represe
molecular phenotype (increase or decrease) on the injected side of the embryo compared to
VP16 was induced to upregulate Notch signaling at stage 10, renal marker expression was re
n= 23). Conversely, when ER-Su(H)DBM was induced by 17β-estradiol to suppress Notch sig
evi167% of embryos, n= 21; pax8 72% of embryos, n= 18). If GR-Su(H)VP16 was induced at
observed (lim1 80% of embryos, n= 20; evi1 78% of embryos, n= 23; pax8 71% of embryos,
ER-Su(H)DBM and dexamethasone to upregulate Notch signaling (B–C), 17β-estradiol to dow
Notch signaling (F–G) were added to the culture medium and examined for pax8 expression
molecular phenotype of decreased (C), increased (E), or normal (G) pax8 expression.
290 C.M. Miazga, K.A. McLaughlin / Developmental Biology 333 (2009) 285–296Notch signaling (data not shown). There was no statistically signiﬁcant
difference in molecular phenotypes between embryos exposed to
upregulated Notch signaling that was restricted to stages 10–14 and
the no hormone control embryos (χ2 =3.79, df=2, p=0.15).
The ability of cells to retain their cardiac fate appears to be only a
transient property. Unlike the rescue of the aberrant molecular
phenotype that resulted when the induction of Notch signaling was
restricted to primarily gastrula stages (stgs. 10–14), if the window of
activated Notch signaling was increased to extend through neurula
stages (stgs. 10–15), the ability to rescue cardiac ﬁeld markers was
markedly reduced (53% of embryos normal nkx2.5 expression,
n=103) (Fig. 4). Indeed, when Notch signaling was extended for
just a few hours more, through the early neural-fold stages (stgs. 10–
16), cardiac ﬁeld marker expression was dramatically decreased on
the injected side of embryos (30% of embryos normal nkx2.5
expression, n=92), similar to when only dexamethasone is added
to the culture medium (Fig. 4). Chi-squared analysis veriﬁed there was
no signiﬁcant difference among these treatment groups (χ2 =5,
df=2, p=0.08). Combined, these data identify a critical and discrete
role for Notch signaling during the prepatterning of the cardiac
mesoderm that is completed by the onset of neurulation. These data
are also consistent with the endogenous expression pattern of Notch
receptor and ligand transcripts that are excluded from the developing
heart region in early neurula embryos (Fig. 1).
In addition to the cardiac markers examined, molecular markers of
another mesodermal derivative, the pronephric kidney were also
analyzed in response to alterations in Notch signaling (Fig. 5). Similar
towhat was observed during early cardiogenesis, when embryos were
co-injected with GR-Su(H)VP16 and ER-Su(H)DBM and just dexa-
methasone (DEX) was added at the onset of gastrulation to induce
Notch signaling, renal markers were dramatically reduced (decreased
expression: lim1 75% of embryos, n= 16; evi1 91% of embryos,uring kidney ﬁeld patterning can be rescued. Embryos were co-injected with GR-Su(H)
ryos were examined for the expression of renal markers lim-1, evi1, and pax8 via in situ
nt the proportion of embryos from two experiments observed to contain an aberrant
the uninjected side (n= 16–27 embryos for each treatment group). (A)When GR-Su(H)
duced (lim175% of embryos, n= 16; evi1 91% of embryos, n= 23; pax8 74% of embryos,
naling, an increase in renal gene expression was observed (lim171% of embryos, n= 21;
stage 10 and ER-Su(H)DBM was induced at stage 14, normal renal marker expressionwas
n= 21). (B–G) Representative images of embryos co-injected with GR-Su(H)VP16 and
nregulate Notch signaling (D–E), or both hormones to upregulate and then moderate
. Images are lateral views with anterior facing outwards. Arrows indicate the observed
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increased renal gene expression, was observed when only E2 was
added to co-injected embryos (increased expression: lim1 71% of
embryos, n= 21; evi1 67% of embryos, n= 21; pax8 72% of embryos,
n= 18). In contrast, when GR-Su(H)VP16 was induced at stage 10
and ER-Su(H)DBM was induced at stage 14, renal markers were
normally expressed (normal expression: lim180% of embryos, n= 20;
evi1 78% of embryos, n= 23; pax8 71% of embryos, n= 21).
Representative embryos of the phenotypes observed with pax8
expression are shown (Figs. 5B–G).
Suppression of Notch signaling during gastrulation results in the
premature expression of cardiac ﬁeld genes
The results described above suggest that the role for Notch
signaling during gastrulation is to help regulate the timing of cardiac
ﬁeld marker expression. To investigate this possibility, we examined
the effects of suppressing Notch signaling in gastrula stage embryos.
Embryos injected with GR-Su(H)DBM were allowed to develop until
just prior to the onset of gastrulation when the Notch suppressing
construct was induced. In order to examine heart ﬁeld marker
expression patterns in whole embryos, mid-gastrula stage (stgs. 11–
11.5) embryos were examined using in situ hybridization (Fig. 6).
Whilst using more sensitive methods of detection such as RNase
protection assays, very low levels of nkx2.5 transcripts have been
reported in 11.5 gastrula stage embryos (Evans et al., 1995) and late-
gastrula embryos (stage 12.5) via RT-PCR (Small et al., 2005), several
other studies have reported that expression cannot be detected until
early neurula stages (Chang et al., 2001; Nagao et al., 2008; Tonissen
et al., 1994). Taking advantage of the previously reported low levels
of nkx2.5 expression during gastrulation, embryos in which Notch
signaling was suppressed during gastrulation were examined for the
expression of heart ﬁeld genes. Interestingly, consistent with Notch
signaling playing a role in mediating the timing of early heart ﬁeld
patterning, cardiac precursor cells were found to robustly express
cardiac ﬁeld genes in response to suppressed Notch signaling in
injected embryos (Fig. 6B nkx2.5 expressed in 76% of embryos,
n= 117; 6D tbx5 expressed in 79% of embryos, n= 86). Expression
of heart ﬁeld transcripts were rarely detected via in situ hybridizationFig. 6. Suppression of Notch signaling during gastrulation results in the robust
expression of cardiac ﬁeld genes. Gastrula 11–11.5 stage embryos are oriented laterally,
vegetal to the left. (A, C) During gastrulation, cardiac ﬁeld marker transcripts nkx2.5 and
tbx5 are not detected by in situ hybridization analysis in uninjected embryos. (B, D) One
blastomere of cleavage-stage embryos was injected with mRNAs encoding GR-Su(H)DBM
plus a lineage marker. At the onset of gastrulation (stg. 10) constructs were induced
via the addition of hormone. When Notch signaling was downregulated during heart
ﬁeld speciﬁcation, the expression of both nkx2.5 (B; 76% of embryos, n=117) and tbx5
(D; 79% of embryos, n=86) robustly expressed in the migrating cardiac precursor cell
population, whereas expression in uninjected embryos is difﬁcult to detect via in situ
hybridization at these stages (A, C). Black arrows denote the injected side of embryos.
Percents are based on the proportion of embryos with the molecular phenotype
indicated across triplicate experiments performed on three separate days.in injected embryos not exposed to hormone (nkx2.5 expressed in
12% of injected embryos, n=52; tbx5 expressed in 17% of injected
embryos, n=66), or uninjected-control sibling embryos (Figs. 6A, C).
The enhanced expression of cardiac ﬁeld genes was restricted to cells
that were positive for the co-injected lineage label, and located in the
heart-forming mesoderm that ﬂanks the Spemann organizer. To our
knowledge, this is the ﬁrst time that the heart primordia have been
shown to robustly express numerous cardiac ﬁeld markers in vivo
prior to reaching the ventral midline where cardiac differentiation
normally occurs.
The precocious enhanced expression of multiple cardiac ﬁeld
markers suggests that the timing of cardiac development may be
accelerated in response to downregulated Notch signaling. To test this
hypothesis, the cardiac muscle markers cardiac actin, mhcα, and tni
were examined at stages before they are normally transcribed
(Drysdale et al., 1994; Logan and Mohun, 1993; Mohun et al., 1984).
None of the markers examined were prematurely expressed in the
cardiac region in response to downregulated Notch signaling (data not
shown). Importantly, dissimilar from heart ﬁeld gene expression,
when the expression of markers used to examine another mesoder-
mal tissue, the renal ﬁeld, were examined during gastrulation in
embryos exposed to reduced Notch signaling, ectopic expression of
lim1 and pax8 was not observed.
During gastrulation, misregulated Notch signaling inﬂuences the
expression of GATA4
Once a role for Notch signaling during gastrulation was identiﬁed,
we began to examine possible mechanisms of how Notch regulates
these earliest stages of cardiac formation. For example, it is possible
that Notch signaling inhibits the development of the heart ﬁeld
mesoderm by antagonizing proteins such as GATA-transcription
factors that are normally associated with cardiomyocyte differentia-
tion. GATA-binding proteins are expressed during multiple stages of
development, such as the leading edge mesoderm during gastrulation
(Fletcher et al., 2006), as well as immediately following gastrulation
when the cardiac ﬁeld is being patterned (Haworth et al., 2008; Jiang
and Evans, 1996; Kelley et al., 1993). Additionally, GATA proteins can
regulate the expression of cardiac genes both in vivo and in vitro
including the transcription factor nkx2.5, facilitating the differentia-
tion of cardiomyocytes (Brewer et al., 2005; Brown et al., 2004;
Grepin et al., 1997; Klinedinst and Bodmer, 2003; Latinkic et al.,
2003; Zhao et al., 2008). Given that some of our earlier observations
revealed that the misregulation of Notch signaling during early
development resulted in altered expression of other cardiac ﬁeld
markers (nkx2.5 and tbx5; Figs. 3–6), we explored whether GATA4
expression was also affected by aberrant Notch signaling.
As described above, one blastomere was injected with mRNAs
encoding either GR-Su(H)VP16 or GR-Su(H)DBM and inducing hor-
mone was added to the culture medium at the onset of gastrulation.
One to 2 h later (mid-gastrula), embryos were ﬁxed and in situ
hybridization analysis was performed to detect GATA4 transcripts. As
Fig. 7 illustrates, similar to what was observed with other genes
expressed in the cardiac ﬁeld, upregulating Notch signaling at stage 10
resulted in a reduction of GATA4 expression (71% of embryos, n= 77)
(Figs. 7A, C). In sharp contrast, the downregulation of Notch signaling
during these stages resulted in increased GATA4 expression (76% of
embryos, n= 110) (Figs. 7A, D).
In addition to upregulating all Notch-responsive HES genes
simultaneously, the effects of inducing an individual mediator of
Notch signaling during gastrulation was also examined. Cleavage-
stage embryos were injected with mRNAs encoding a hormone
inducible Esr9 construct (Esr9-GR) and dexamethasone was added to
the culture medium at the onset of gastrulation. A few hours after the
addition of hormone (mid-gastrula), embryos were collected and
analyzed for GATA4 expression (Fig. 7A). Similar to results observed in
Fig. 7. In addition to the premature induction of cardiac ﬁeld markers resulting from aberrant activation of GATA4 during gastrulation, the misregulation of Notch signaling results in
altered levels of GATA4 transcription in gastrula stage embryos. Embryos were injected with one of the following constructs plus a pink lineage marker: GR-Su(H)VP16 (upregulate
Notch signaling), GR-Su(H)DBM (downregulate Notch signaling), Esr9-GR (upregulate one Notch-responsive HES gene), or GATA4-GR (upregulate GATA4). Constructs were induced
at stage 10 by the addition of dexamethasone to the culture medium, collected approximately 1 h later, and examined for GATA4, nkx2.5, or tbx5 expression via in situ hybridization.
The predominant molecular phenotype (increased or decreased expression) is reported as the percentage of embryos with the observed phenotype calculated across three
experiments. When Notch signaling was increased following injection and induction of either GR-Su(H)VP16 or Esr9-GR, GATA4 expressionwas reduced or ablated (71% of injected/
induced embryos, n= 77; 74% of injected/induced embryos, n= 53, respectively). Unlike what is observed when Notch signaling is upregulated, when signaling through Notch was
suppressed at these stages, GATA4 expression was expanded (76% of injected/induced embryos, n= 110). Interestingly when the temporally inducible GATA4-GR construct was
induced at the onset of gastrulation, the expression of both nkx2.5 (83% of embryos, n= 42) and tbx5 (82% of embryos, n= 61) was activated prematurely in late-gastrula embryos.
This phenotype is similar to that following suppression of Notch signaling (Fig. 6). For each construct used, injected embryos not exposed to hormonewere also examined in order to
determine the level of leakiness of the inducible constructs for these experiments. (B–D) Representative images of an uninjected-control embryo or embryos injected with GR-Su(H)
VP16 or GR-Su(H)DBM demonstrating the observed GATA4 expression phenotypes. While GATA4 is detected in cells neighboring the dorsal lip of the blastopore (arrows in B), when
Notch signaling is upregulated in cells in this region, GATA4 expression is reduced (arrowhead in C). Conversely, when Notch signaling is downregulated GATA4 is robustly expressed
by migrating precardiac cells in addition to expression in cells lining the dorsal lip of the blastopore (arrowheads and arrows, respectively, in D). Embryos in panels B–C are oriented
ventrally. The embryo in panel D is oriented laterally, with the blastopore facing down.
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one of the Notch-responsive HES genes, Esr9, resulted in a comparable
reduction of GATA4 expression (74% of embryos, n= 53).
Similar to the effect of suppressing Notch signaling during gastrulation,
the aberrant activation of GATA4 during gastrulation prematurely
induces the expression of cardiac ﬁeld markers
The misexpression of GATA4 in embryos exposed to altered levels
of Notch signaling during gastrulation (Fig. 7), suggests that Notch
might regulate the timing of cardiac gene expression via a GATA-
mediated mechanism. Thus, we examined whether the aberrant
activation of GATA4 during gastrulation could induce cardiac ﬁeld
markers prematurely, akin to the effects observed when Notch
signaling was suppressed during these stages of cardiogenesis. For
these experiments, embryos were injected with mRNAs encoding a
temporarily inducible GATA4 construct (GATA4-GR) plus a lineage
marker. At the onset of gastrulation, hormone was added to the
culture medium to induce injected constructs. A few hours after the
addition of hormone (mid-gastrula stages), embryos were examined
by in situ hybridization for the expression of two cardiac ﬁeld genes,
nkx2.5 and tbx5. Comparable to the established ability of GATA-family
members to induce the expression of cardiac markers in numerous
model systems (Heicklen-Klein et al., 2005; Latinkic et al., 2003;
Molkentin et al., 1994; Perrino and Rockman, 2006), and identical to
the effects of suppressing Notch signaling during gastrulation (Fig. 6),
embryos in which GATA4 was upregulated at gastrula stages robustlyexpressed both nkx2.5 and tbx5 prior to the end of gastrulation
(nkx2.5 83% of embryos n=42; tbx5 82% of embryos n= 61) (Fig. 7).
Accordingly, both GATA4 expression and suppressed Notch signaling
during gastrulation resulted in the prematurely enhanced expression
of heart ﬁeld transcripts normally expressed at later stages of
cardiogenesis.
GATA4 expression is sufﬁcient to rescue the mispatterning of cardiac
ﬁeld mesoderm resulting from aberrant Notch signaling during
early cardiogenesis
Although the results described in the previous section suggest a
role for Notch signaling during the prepatterning of the cardiac
mesoderm via modulating GATA4 activity, the ability of GATA4 to
rescue the ablation of heart ﬁeld markers observed in embryos
exposed to activated Notch signaling would provide further evidence
for this role. Thus, we examined whether the molecular phenotype
observed after Notch signaling was activated during gastrulation
(decreased expression of cardiac markers), could be rescued if GATA4
was induced before embryos completed neurulation. Embryos were
co-injected with GR-Su(H)VP16 and an estrogen-inducible version of
GATA4 (GATA4-ER). As before, Notch signaling was activated at the
onset of gastrulation via the addition of dexamethasone. After
gastrulation was completed, GATA4-ER was induced via the addition
of 17β-estradiol to the culture medium, and at tailbud stages gene
transcription was assayed (Fig. 8). Unlike what was observed when
either Notch signaling is upregulated at the onset of gastrulation
Fig. 8. GATA4 can rescue cardiac development inhibited by Notch signaling. Embryos
were co-injected with GR-Su(H)VP16 and GATA4-ER. Previously injected embryos had
either individual hormones, or both hormones (Dex and E2) added to the culture
medium at the stages indicated on the graph. Prior to the fusion of the heart ﬁeld (stgs
23–28), in situ hybridization analysis was used to examine nkx2.5 expression on the
injected and uninjected side of embryos. As before when Notch signaling is upregulated
(Dex10), a loss in cardiac ﬁeld markers was observed (69% of GR-Su(H)VP16-injected
embryos, n= 84), whereas the over-expression of GATA4 (E214) resulted in a dramatic
expansion of nkx2.5 expression (79% of GATA4-ER-injected embryos, n= 91). The
induction of GR-Su(H)VP16 (Notch on) at the onset of gastrulation (Dex10), combined
with the over-expression of GATA4 after gastrulation was completed (E214), rescued
the decreased nkx2.5 expression normally caused by aberrant activation of Notch
signaling (55% of embryos with normal expression, 34% of embryos with decreased
expression, 12% of embryos with increased expression, n= 137). As the graph
illustrates, a similar rescue of mispatterned heart ﬁeld marker expressionwas observed
when both constructs were induced simultaneously (Dex14/E214). Reported percen-
tages represent the proportion of embryos with the described phenotype across three
replicate experiments conducted on different days.
Fig. 9. GATA4 can rescue cardiac development inhibited by Esr9. Embryos were co-
injected with Esr9-GR and GATA4-ER as described in the Materials and methods.
Dexamethasone was added to the culturemedium to induce Esr9-GR to upregulate Esr9
expression and 17β-estradiol was added to induce GATA4-ER at the stages indicated on
graph. Percentages are the average number of embryos from three experiments
observed to contain misexpression of nkx2.5 on the injected side of embryos when
compared to the uninjected-control side. Embryos were examined for the cardiac ﬁeld
marker nkx2.5 via in situ hybridization between stages 25–27, prior to the fusion of the
two heart ﬁelds. As before, when Esr9 is upregulated at the onset of gastrulation, a loss
in cardiac ﬁeld markers was observed (57%, n= 96). The opposite molecular phenotype
is observed when GATA4 is induced after gastrulation is completed (increased nkx2.5
expression in 67% of embryos, n= 99). Similar to results reported in Fig. 7, when the
Notch-responsive bHLH protein Esr9 is upregulated at stage 10 and the transcription
factor GATA4 is over-expressed at stage 14, a rescue of the abnormal (increased and
decreased phenotypes) cardiac ﬁeld marker expression is observed (67% of embryos
have normal nkx2.5 expression, n= 147).
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GATA4 is upregulated at early neurula stages (increased nkx2.5
expression in 79% of embryos, n= 91), nkx2.5 expression remained
unaffected in more than half the embryos examined when GATA4 was
upregulated at stage 14 to offset the effects of activated Notch
signaling at stage 10 (n= 137: unchanged nkx2.5 expression in 54% of
embryos; increased nkx2.5 expression in 12% of embryos; decreased
nkx2.5 expression in 34% of embryos) (Fig. 8). A statistically signiﬁcant
reduction in the number of embryos displaying either aberrant
molecular phenotype was observed in embryos induced to simulta-
neously activate both Notch (Dex10) and GATA4 (E214) constructs
(χ2 =126, df=2, p b0.001). Interestingly, although ablated cardiac
gene expression resulting from upregulated Notch signaling could be
rescued when Notch was suppressed at the end of gastrulation (stg.
14; Fig. 4), cardiac gene expression could be rescued using GATA4 for a
longer window of development, well into late neurula stages (stg. 18;
nkx2.5 expression was normal in 48% of embryos, n= 33). However,
the upregulation of GATA4 speciﬁcally rescued the observed depletion
of cardiac transcripts and not the expression of other mesodermal
genes. For example, a similar rescue was not observed when
examining renal ﬁeld markers (data not shown). Taken together,
these data provide additional support that GATA4 is a tissue speciﬁc
target of Notch signaling necessary to regulate the establishment of
the primary heart ﬁeld.
GATA4 can restore cardiac gene expression inhibited by the Notch target
gene Esr9
Because the Notch-responsive bHLH gene, esr9, is expressed at a
time and place consistent with mediating the function of Notch
signaling during cardiac precursor development, the ability of GATA4to rescue the effects of Esr9 activation was examined. For these
experiments GATA4-ER and Esr9-GRmRNAswere co-injected into one
blastomere of cleavage-stage embryos. At the desired stage of
development, individual constructs were induced via the addition of
the appropriate hormone (Fig. 9). Similar to results described in Fig. 7,
when just Esr9 was induced at the onset of gastrulation, nkx2.5
expression decreased on the injected side of embryos (57% of
embryos, n= 96) (Fig. 9). As before, when GATA4-ER was induced
after gastrulation was completed, a dramatic increase of nkx2.5
expression was observed (67% of embryos, n= 99) (Fig. 9). To
determine whether GATA4 was able to rescue the loss of cardiac gene
expression imposed by activated Esr9, Esr9-GR was induced at stage
10 and GATA4-ER was subsequently induced at stage 14. Interestingly,
comparable to the GATA4 rescue of activated Notch signaling (Fig. 8),
the over-expression of GATA4 was able to rescue the loss of cardiac
ﬁeld markers resulting from upregulating Esr9 (nkx2.5 normal
expression in 67% of embryos, n= 147) (Fig. 8). Taken together,
these data provide strong evidence for a role for Notch signaling in
regulating cardiac ﬁeld formation that is mediated via Esr9 and
GATA4.
Discussion
Our results, combinedwith evidence from the literature (Abe et al.,
2004; Coffman et al., 1990; Kiyota et al., 2001; Lopez et al., 2003, 2005;
Ma et al., 1996; Wittenberger et al., 1999), demonstrate that a Notch
receptor, ligands, and downstream effectors are all expressed at the
appropriate time and place consistent with a role for this signaling
pathway during the earliest stages of cardiac formation. In addition,
we demonstrate that while the upregulation of Notch signaling results
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rise to a cardiac fate when aberrantly activated signaling is restricted
to the developmental window of gastrulation. We also provide
evidence that Notch signaling is necessary during this window of
heart development to restrict ﬁeld marker gene expression in a
spatiotemporal manner. Lastly, the regulation of cardiac ﬁeld forma-
tion by Notch signaling is, at least in part, mediated by the Notch
effector protein Esr9 and the cardiac transcription factor GATA4.
While a role for Notch signaling during later stages of cardiac
differentiation andmorphogenesis has beenwidely studied (Beis et al.,
2005; Garg et al., 2005; Han and Bodmer, 2003; Lorent et al., 2004;
McCright et al., 2002; Schroeder et al., 2003) our lab was the ﬁrst to
identify a previously uncharacterized role for this pathway during
heart ﬁeld speciﬁcation. This ﬁnding is in agreement with expression
proﬁle data from our laboratory and others indicating that Notch
pathway components are expressed in the presumptive mesoderm
during gastrulation, when cardiac ﬁeld speciﬁcation occurs (Figs. 1, 2
and Sater and Jacobson, 1989; Coffman et al., 1990; Nascone and
Mercola, 1995; Ma et al., 1996; Wittenberger et al., 1999; Kiyota et al.,
2001; Abe et al., 2004; Lopez et al., 2003, 2005).
Recently, several studies have reported a role for Notch signaling in
promoting cardiomyogenesis in a variety of different stem cell
populations (Boni et al., 2008; Campa et al., 2008; Collesi et al.,
2008). For example, in studies using cardiac progenitor cells isolated
frommouse hearts, the activation of signalingmediated via the Notch-
1 receptor, promoted the re-entry of quiescent cardiac progenitor cells
(CPCs) into the cell cycle, expanding progenitor pools. Additionally,
activation of Notch signaling in these CPCs promoted the formation of
cardiac myocytes and the cardiac transcription factor Nkx2.5 was
shown to be a direct transcriptional target of the NotchICD/RBP-Jκ [Su
(H)] protein complex (Boni et al., 2008). Interestingly and similar to
the premature expression of cardiac ﬁeld markers we observed when
Notch signaling was suppressed during gastrulation, Nemir et al.
(2006) demonstrated that the downregulation of Notch-1 in
embryonic stem cells also promoted cardiogenesis (Nemir et al.,
2006). Furthermore and reminiscent of the ablation of heart ﬁeld
markers we observed when aberrant activation of Notch was
extended through neurula stages, Schroeder et al. (2006) described
a reduction in the number of functional cardiomyocyte colonies
observed when Notch signaling was activated in ES derived
mesodermal progenitors (Schroeder et al., 2006). Therefore, because
Notch signaling mediates such disparate cellular behaviors during
cardiomyogenesis, characteristics such as age, location, and cell
history must be considered when trying to understand how this
signaling pathway functions during speciﬁc, ﬁnite windows of
development.
The research presented in this paper supports a model by which
Notch signaling functions to restrict the development of the
precardiac mesoderm during gastrulation before cells migrate to a
common anterioventral destination where cardiomyocyte differentia-
tion occurs. Previous work demonstrated that cells explanted from the
precardiac region of gastrula embryos are competent to develop into
beating cardiac tissue (Nascone and Mercola, 1995; Sater and
Jacobson, 1989, 1990). However, cardiac-speciﬁc gene expression is
lacking or only weakly detected in vivo until early neurula stages
suggesting that an inhibitory signal is in place to prevent cardiac gene
expression until these cells have reached their ﬁnal destination at the
ventral midline. As Notch signaling has been shown to inhibit
differentiation and maintain precursor cell populations as a way of
regulating cell fate decisions in numerous tissues, it is possible and
consistent with results described in this study, that the role for Notch
signaling during gastrulation is to inhibit the induction of cardiac ﬁeld
genes during gastrulation (Ishiko et al., 2005; le Roux et al., 2003; Ye
et al., 2004).
In order to begin to better understand the role for Notch signaling
during cardiac speciﬁcation, we began to examine downstreammediators of Notch belonging to the HES family of transcription
factors. Results from the studies discussed herein provide new insights
into potential mechanisms used to regulate the timing of heart ﬁeld
induction. Because the Notch-responsive HES gene Esr9 is expressed
in the marginal zone mesoderm during gastrulation, we focused our
analysis on this bHLH protein. In addition to being expressed in a time
and place consistent with playing a role in the development of cardiac
mesoderm, we observed that similar to the effects of activated Notch
signaling during gastrulation, prolonged Esr9 activity also inhibited
the expression of heart ﬁeld markers (nkx2.5, tbx5 and GATA4).
Moreover, the capability of GATA4 to rescue the ablation of heart ﬁeld
markers caused by aberrantly activated Esr9, strongly suggests that
Notch/Esr9 signaling might regulate GATA4 activity during gastrula-
tion. This is further supported by experiments demonstrating that
the upregulation of GATA4 in gastrula embryos also results in robust
expression of nkx2.5 and tbx5 in precardiac cells, akin to the
molecular phenotypes observed when Notch signaling is down-
regulated in these cells. Consistent with this notion, the endogenous
expression of Notch signaling components is normally reduced just
prior to the detection of robustly expressed nkx2.5 transcripts at
time when GATA4 would presumably act to initiate cardiac gene
expression in the heart ﬁeld.
The ability of Esr9 proteins to regulate GATA4 activity may be
mediated by several possible mechanisms. For example, Notch target
genes belonging to the Hey family of proteins (closely related to HES
family members) can regulate GATA4 activity by inhibiting transcrip-
tion as well as through protein–protein interactions (Fischer et al.,
2005; Kathiriya et al., 2004; Xiang et al., 2006). Future work will
investigate if a similar set of regulatorymechanisms is used tomediate
the interaction between Esr9 and GATA4 during the formation of the
embryonic heart ﬁeld.Acknowledgments
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